MX2018015140A - Firmas de biomarcadores de lupus eritematoso sistemico y sus usos. - Google Patents

Firmas de biomarcadores de lupus eritematoso sistemico y sus usos.

Info

Publication number
MX2018015140A
MX2018015140A MX2018015140A MX2018015140A MX2018015140A MX 2018015140 A MX2018015140 A MX 2018015140A MX 2018015140 A MX2018015140 A MX 2018015140A MX 2018015140 A MX2018015140 A MX 2018015140A MX 2018015140 A MX2018015140 A MX 2018015140A
Authority
MX
Mexico
Prior art keywords
systemic lupus
lupus erythematosus
biomarker
biomarker signatures
amount
Prior art date
Application number
MX2018015140A
Other languages
English (en)
Inventor
Borrebaeck Carl
Wingren Christer
Delfani Payam
Dexlin Mellby Linda
Original Assignee
Immunovia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunovia Ab filed Critical Immunovia Ab
Publication of MX2018015140A publication Critical patent/MX2018015140A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/104—Lupus erythematosus [SLE]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Abstract

La invención proporciona un método para determinar un estado patológico asociado al lupus eritematoso sistémico en un sujeto que comprende las etapas de (a) proporcionar una muestra a analizar; y (b) medir la presencia y/o la cantidad en la muestra de prueba de uno o más biomarcadores seleccionados del grupo definido en la Tabla A, en donde la presencia y/o la cantidad en la muestra de prueba del uno o más biomarcadores seleccionados del grupo definido en la Tabla A evidencian un estado patológico asociado al lupus sistémico. La invención también proporciona una matriz y un kit adecuados para usar en los métodos de la invención.
MX2018015140A 2016-06-07 2017-06-07 Firmas de biomarcadores de lupus eritematoso sistemico y sus usos. MX2018015140A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1609951.7A GB201609951D0 (en) 2016-06-07 2016-06-07 Biomarkers signatures and uses thereof
PCT/EP2017/063855 WO2017211896A1 (en) 2016-06-07 2017-06-07 Biomarker signatures of systemic lupus erythematosus and uses thereof

Publications (1)

Publication Number Publication Date
MX2018015140A true MX2018015140A (es) 2019-08-16

Family

ID=56508210

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018015140A MX2018015140A (es) 2016-06-07 2017-06-07 Firmas de biomarcadores de lupus eritematoso sistemico y sus usos.

Country Status (12)

Country Link
US (2) US20200041504A1 (es)
EP (1) EP3465209A1 (es)
JP (1) JP2019526810A (es)
KR (1) KR20190038791A (es)
CN (1) CN109690312A (es)
AU (1) AU2017277583A1 (es)
BR (1) BR112018075223A2 (es)
CA (1) CA3026574A1 (es)
GB (1) GB201609951D0 (es)
MX (1) MX2018015140A (es)
RU (1) RU2018142846A (es)
WO (1) WO2017211896A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201014837D0 (en) 2010-09-07 2010-10-20 Immunovia Ab Biomarker signatures and uses thereof
EP3867645A4 (en) * 2018-10-18 2022-07-13 Oklahoma Medical Research Foundation SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) DISEASE ACTIVITY IMMUNE INDEX BIOMARKERS THAT CHARACTERIZE DISEASE ACTIVITY
GB201904472D0 (en) * 2019-03-29 2019-05-15 Immunovia Ab Methods, arrays and uses thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE12586T1 (de) 1980-05-02 1985-04-15 Edward P Davis Beinentlastungsgeraet.
US4486530A (en) 1980-08-04 1984-12-04 Hybritech Incorporated Immunometric assays using monoclonal antibodies
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US5856090A (en) 1994-09-09 1999-01-05 The Scripps Research Institute DNA-methylase linking reaction
GB9703369D0 (en) 1997-02-18 1997-04-09 Lindqvist Bjorn H Process
US20070141627A1 (en) * 2005-10-19 2007-06-21 Behrens Timothy W Systemic Lupus Erythematosus
GB201014837D0 (en) * 2010-09-07 2010-10-20 Immunovia Ab Biomarker signatures and uses thereof
WO2014008426A2 (en) * 2012-07-06 2014-01-09 Ignyta, Inc. Diagnosis of systemic lupus erythematosus
WO2015038069A1 (en) * 2013-09-11 2015-03-19 Singapore Health Services Pte Ltd Identification of novel biomarkers of flares of systemic lupus erythematosus
GB201319878D0 (en) * 2013-11-11 2013-12-25 Immunovia Ab Method, Array and use thereof
GB201410226D0 (en) * 2014-06-09 2014-07-23 Immunovia Ab Methods and arrays for use in the same
US20170315119A1 (en) * 2014-10-07 2017-11-02 University Health Network Urinary biomarkers for sle and lupus nephritis

Also Published As

Publication number Publication date
BR112018075223A2 (pt) 2019-03-19
GB201609951D0 (en) 2016-07-20
WO2017211896A1 (en) 2017-12-14
CA3026574A1 (en) 2017-12-14
RU2018142846A3 (es) 2020-09-16
US20200041504A1 (en) 2020-02-06
CN109690312A (zh) 2019-04-26
WO2017211896A9 (en) 2019-03-14
EP3465209A1 (en) 2019-04-10
KR20190038791A (ko) 2019-04-09
JP2019526810A (ja) 2019-09-19
US20230063017A1 (en) 2023-03-02
AU2017277583A1 (en) 2019-01-03
AU2017277583A9 (en) 2019-08-01
RU2018142846A (ru) 2020-07-09

Similar Documents

Publication Publication Date Title
EP3800253A3 (en) Prostate cancer detection kit or device, and detection method
EP3816303A3 (en) Breast cancer detection kit or device, and method for detecting breast cancer
WO2017050939A3 (en) Method and array for diagnosing pancreatic cancer in an individual
GB201014837D0 (en) Biomarker signatures and uses thereof
EP3636769A4 (en) TEST KIT FOR SAMPLE NUCLEIC ACID MEASUREMENT, REAGENT AND USE OF IT
WO2015067969A3 (en) Method, array and use thereof for determining pancreatic cancer
EP3757225A3 (en) Pancreatic cancer detection kit or device, and detection method
EP3971299A3 (en) Colorectal cancer detection kit or device, and detection method
EP3654036A3 (en) Stomach cancer biomarker and detection method
EP3967769A3 (en) Lung cancer detection kit or device, and detection method
MX2018013621A (es) Metodo, matriz y uso de estos.
MX363201B (es) Procedimiento, matriz y uso para determinar la presencia de cancer pancreatico.
MX2019008911A (es) Metodos, matrices y usos de estos.
BR112016019836A2 (pt) método para analisar uma amostra de um sujeito, dispositivo de diagnóstico para utilização no diagnóstico da endometriose, kit, uso de um biomarcador, e, método para aumentar uma resposta de anticorpos em um sujeito
EP3487407A4 (en) METHOD AND SYSTEMS FOR MEASURING ANALYTES USING CALIBRATABLE TEST STRIPS
MX2021006791A (es) Metodos y composiciones para detectar proteinas mal plegadas.
WO2014186761A3 (en) Methods for determining responsiveness to an anti-cd47 agent
EP3578959A3 (en) Method for reading test strips
EP3605092A4 (en) KIT AND METHOD FOR MEASURING A SUBSTANCE MEASURED IN A BIOLOGICAL SAMPLE
WO2015189591A3 (en) Method and arrays for use in diagnosing early breast cancer
EP3605093A4 (en) KIT AND METHOD FOR MEASURING A SUBSTANCE MEASURED IN A BIOLOGICAL SAMPLE
WO2014162008A3 (en) Biomarker signatures for predicting drug response in hodkin's lymphoma
MX2018015140A (es) Firmas de biomarcadores de lupus eritematoso sistemico y sus usos.
EP3557259A3 (en) Methods and arrays for use in the same
EP2937421A3 (en) Biomarker for predicting effect of an anti-C-met antibody